Mortality prediction algorithms for patients undergoing primary percutaneous coronary intervention
This article that appeared on Page: 1706-1720, Vol 12, No 4 (April 2020) Issue of the Journal of Thoracic Disease (JTD) (1), contained ONE mistake.
The detailed correction is as below:
Table 2 was erroneously typeset. In column #3 (“Source of Data”) all cell contain “Multi Center Registry” to the contrary of the submitted “Table 2”, which negatively affects the scientific content of the paper.
Table 2. Validation studies of mortality risk models in patients with ST-segment elevation myocardial infarction.
| Author, year | Study characteristics | C-Statistic (95% CI) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical setting | Treatment | Source of data | Time of end point | Event rate (%) | TIMI, n=10 | PAMI, n=6 | Zwolle, n=5 | CADILLAC, n=6 | APEX-AMI, n=1 | NCDR CathPCI, n=2 | AR-G, n=2 | EH STEMI PCI, n=1 | Dynamic TIMI, n=2 | GRACE, n=17 | ALPHA, n=2 | ||
| Morrow, 2001 | STEMI | PPCI | Multi-Center Registry | In-hospital | NR/15,348 (NA) | 0.80 (NR) | |||||||||||
| De Luca, 2004 | STEMI | PPCI | Single-Center Registry | 30 days | 27/747 (3.6) | 0.90 (NR) | |||||||||||
| Halkin, 2005 | STEMI | PPCI | Multi-Center RCT | 30 days | 24/900 (2.7) | 0.70 (NR) | 0.78 (NR) | 0.74 (NR) | 0.81 (NR) | ||||||||
| Halkin, 2005 | STEMI | PPCI | Multi-Center RCT | 1 year | 39/900 (4.3) | 0.69 (NR) | 0.77 (NR) | 0.74 (NR) | 0.78 (NR) | ||||||||
| Lev, 2008 | STEMI | PPCI | Single-Center Registry | 30 days | 31/855 (3.6) | 0.72 (NR) | 0.74 (NR) | 0.82 (NR) | 0.47 (NR)* | ||||||||
| Lev, 2008 | STEMI | PPCI | Single-Center Registry | 1 year | 50/855 (5.8) | 0.75 (NR) | 0.75 (NR) | 0.81 (NR) | 0.48 (NR)* | ||||||||
| Elbarouni, 2009 | STEMI | Not Specified | Multi-Center Registry | In-hospital | 171/3,186 (5.4) | 0.83 (0.80 to 0.86)* | |||||||||||
| Peterson, 2010 | STEMI | PPCI | Multi-Center Registry | In-hospital | NR/39,889 (NA) | 0.88 (NR) | |||||||||||
| Abu-Assi, 2010 | STEMI | Not Specified | Multi-Center Registry | In-hospital | 178/2,344 (7.6) | 0.86 (0.83 to 0.89)* | |||||||||||
| Abu-Assi, 2010 | STEMI | Not Specified | Multi-Center Registry | 6 months | 126/2,165 (5.8) | 0.79 (0.75 to 0.83)* | |||||||||||
| Chin, 2011 | NSTEMI/STEMI | Not Specified | Multi-Center Registry | In-hospital | 800/16,336 (4.9) | 0.84 (NR) | |||||||||||
| de Mulder, 2011 | STEMI | PCI | Multi-Center Registry | In-hospital | 203/3,969 (5.1) | 0.89 (NR) | |||||||||||
| Yusufali, 2011 | STEMI | Not Specified | Multi-Center Registry | In-hospital | 144/2,986 (4.8%) | 0.86 (NR)* | |||||||||||
| Selvarajah, 2012 | STEMI | Not Specified | Multi-Center Registry | 30 days | 522/4,701 (11.1) | 0.79 (0.77 to 0.81) | |||||||||||
| Raposeiras-Roubín, 2012 | STEMI | Not Specified | Single-Center Registry | In-hospital | 141/1,443 (9.8) | 0.89 (0.87 to 0.92) | 0.91 (0.88 to 0.93)* | ||||||||||
| Méndez-Eirín, 2012 | STEMI | PPCI/Rescue PCI | Single-Center Registry | 30 days | 83/1,503 (5.5) | 0.87 (0.85 to 0.89) | 0.81 (0.79 to 0.83) | 0.90 (0.88 to 0.91) | 0.90 (0.89 to 0.92)* | ||||||||
| Méndez-Eirín, 2012 | STEMI | PPCI/Rescue PCI | Single-Center Registry | 1 year | 105/1,130 (9.3) | 0.85 (0.83 to 0.87) | 0.81 (0.78 to 0.83) | 0.87 (0.84 to 0.89) | 0.85 (0.83 to 0.87)* | ||||||||
| Amin, 2013 | STEMI | PCI | Multi-Center RCT | 1 year | 48/1,829 (2.6) | 0.81 (NR) | |||||||||||
| Timóteo, 2013 | STEMI | PPCI | Single-Center Registry | In-hospital | 33/607 (5.4) | 0.84 (0.77 to 0.92) | 0.92 (0.87 to 0.96)* | ||||||||||
| Timóteo, 2013 | STEMI | PPCI | Single-Center Registry | 30 days | 38/607 (6.3) | 0.83 (0.76 to 0.90) | 0.88 (0.82 to 0.95)* | ||||||||||
| Fox, 2014 | STEMI | Not Specified | Multi-Center Registry | 1 year | NR/1,558 (NA) | 0.84 (NR)* | |||||||||||
| Fox, 2014 | STEMI | Not Specified | Multi-Center Registry | 3 years | NR/1,558 (NA) | 0.82 (NR)* | |||||||||||
| Fujii, 2014 | STEMI | PPCI | Single-Center Registry | In-hospital | 54/412 (13.1) | 0.95 (NR)** | |||||||||||
| Fujii, 2014 | STEMI | PPCI | Single-Center Registry | 1 year | 64/412 (15.5) | 0.92 (NR)** | |||||||||||
| Abelin, 2014 | STEMI | PPCI | Single-Center Registry | 30 days | 39/501 (7.8) | 0.81 (0.74 to 0.87) | 0.75 (0.68 to 0.82) | 0.80 (0.73 to 0.87) | 0.84 (0.78 to 0.90)* | ||||||||
| Littnerova, 2015 | STEMI | PPCI | Single-Center Registry | 6 months | 24/593 (4.0) | 0.72 (0.70 to 0.85) | 0.77 (0.65 to 0.80) | 0.81 (0.73 to 0.88) | 0.82 (0.75 to 0.88) | 0.81 (0.73 to 0.89) | 0.85 (0.78 to 0.93)* | ||||||
| Littnerova, 2015 | STEMI | PPCI | Single-Center Registry | 1 year | 43/593 (7.3) | 0.73 (0.70 to 0.85) | 0.77 (0.66 to 0.80) | 0.80 (0.72 to 0.87) | 0.82 (0.76 to 0.89) | 0.81 (0.74 to 0.89) | 0.86 (0.80 to 0.93)* | ||||||
| Littnerova, 2015 | STEMI | PPCI | Single-Center Registry | 2 years | 53/593 (8.9) | 0.68 (0.64 to 0.79) | 0.72 (0.61 to 0.76) | 0.72 (0.64 to 0.80) | 0.76 (0.69 to 0.83) | 0.75 (0.67 to 0.83) | 0.79 (0.72 to 0.86)* | ||||||
| Littnerova, 2015 | STEMI | PPCI | Single-Center Registry | 3 years | 63/593 (10.6) | 0.66 (0.64 to 0.78) | 0.71 (0.59 to 0.73) | 0.69 (0.61 to 0.76) | 0.74 (0.67 to 0.80) | 0.73 (0.67 to 0.80) | 0.77 (0.70 to 0.83)* | ||||||
| Parenica, 2016 | STEMI | PPCI | Single-Center Registry | 1 year | 40/593 (6.7) | 0.85 (NR)* | |||||||||||
| Huang, 2016 | STEMI | Not Specified | Multi-Center Registry | 1 year | 8/378 (2.1) | 0.94 (NR)** | |||||||||||
| Timóteo, 2016 | ACS | PCI | Single-Center Registry | In-hospital | 96/2,148 (4.5) | 0.87 (0.83 to 0.91) | 0.94 (0.91 to 0.96)* | ||||||||||
| Hizoh, 2017 | STEMI | PPCI | Single-Center Registry | 30 days | 41/505 (8.1) | 0.82 (0.75 to 0.89) | 0.78 (0.70 to 0.88) | 0.81 (0.74 to 0.88) | 0.83 (0.79 to 0.92) | 0.86 (0.79 to 0.92) | 0.86 (0.80 to 0.92)** | 0.87 (0.81 to 0.93) | |||||
| Hizoh, 2017 | STEMI | PPCI | Single-Center Registry | 1 year | 73/505 (14.5) | 0.84 (0.80 to 0.89) | |||||||||||
| Yu, 2017 | NSTEMI/STEMI | PCI | Single-Center Registry | 1 year | 29/728 (4.0) | 0.73 (0.70 to 0.76) | 0.74 (0.71 to 0.77)* | ||||||||||
| Hizoh, 2018 | STEMI | PPCI | Multi-Center Registry | 30 days | 383/5,203 (7.4) | 0.81 (0.79 to 0.83) | 0.87 (0.85 to 0.89)** | 0.86 (0.84 to 0.88) | |||||||||
*, using the GRACE 1.0 model; **, using the GRACE 2.0 model. ACS, acute coronary syndrome; ALPHA, Age, life support, pressure, heart rate, access site; APEX AMI, Assessment of Pexelizumab in Acute Myocardial Infarction; AR-G, Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines; CADILLAC, Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications; EH, EuroHeart; GRACE, Global Registry of Acute Coronary Events; NA, not applicable; NCDR CathPCI, National Cardiovascular Data Registry for Catheterization Percutaneous Coronary Intervention; NR, not reported; PAMI, primary angioplasty in myocardial infarction; PCI, percutaneous coronary intervention; PPCI, primary percutaneous coronary intervention; RCT, randomized controlled trial; STEMI, ST-segment elevation myocardial infarction; TIMI, thrombolysis in myocardial infarction.
The corrected version of Table 2 is presented here (Table 2).
The authors regret the error.
References
- 1.Hizoh I, Domokos D, Banhegyi G, et al. Mortality prediction algorithms for patients undergoing primary percutaneous coronary intervention. J Thorac Dis 2020;12:1706-20. 10.21037/jtd.2019.12.83 [DOI] [PMC free article] [PubMed] [Google Scholar]
